Tumor immunological phenotype-derived gene classification predicts prognosis, treatment response, and drug candidates in ovarian cancer.
作者信息
Guo Chengbin, Tang Yuqin, Liu Zhihai, Chen Chuanliang, Hu Xun, Zhang Yongqiang
机构信息
Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China.
Clinical Bioinformatics Experimental Center, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, China.
出版信息
Genes Dis. 2023 Nov 21;11(5):101173. doi: 10.1016/j.gendis.2023.101173. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Tumor immunological phenotype-derived gene classification predicts prognosis, treatment response, and drug candidates in ovarian cancer.肿瘤免疫表型衍生的基因分类可预测卵巢癌的预后、治疗反应及候选药物。
Genes Dis. 2023 Nov 21;11(5):101173. doi: 10.1016/j.gendis.2023.101173. eCollection 2024 Sep.
2
Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.鉴定与肿瘤免疫表型相关的基因特征，用于预测肝细胞癌的预后、免疫治疗疗效和药物候选物。
Front Immunol. 2022 Apr 12;13:862527. doi: 10.3389/fimmu.2022.862527. eCollection 2022.
3
Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis.卵巢癌中类干细胞基因表达预测 II 型亚型和预后。
PLoS One. 2013;8(3):e57799. doi: 10.1371/journal.pone.0057799. Epub 2013 Mar 11.
4
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.基因表达与突变体表型之间的相关性可预测卵巢癌中的同源重组缺陷及预后。
J Mol Med (Berl). 2014 Nov;92(11):1159-68. doi: 10.1007/s00109-014-1191-9. Epub 2014 Jul 27.
5
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.一种基于新型肿瘤突变负担的风险模型可预测卵巢癌的预后，并与免疫浸润相关。
Front Immunol. 2022 Aug 8;13:943389. doi: 10.3389/fimmu.2022.943389. eCollection 2022.
6
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes.正常细胞起源的基因表达特征可预测卵巢肿瘤的预后。
PLoS One. 2013 Nov 26;8(11):e80314. doi: 10.1371/journal.pone.0080314. eCollection 2013.
7
Macrophages Phenotype Regulated by IL-6 Are Associated with the Prognosis of Platinum-Resistant Serous Ovarian Cancer: Integrated Analysis of Clinical Trial and Omics.IL-6 调控的巨噬细胞表型与铂耐药性浆液性卵巢癌的预后相关：临床试验和组学的综合分析。
J Immunol Res. 2023 Apr 19;2023:6455704. doi: 10.1155/2023/6455704. eCollection 2023.
8
Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.利用一种新颖的计算药物重定位方法（DrugPredict），快速鉴定出用于癌症治疗的有效药物候选物。
Oncogene. 2018 Jan 18;37(3):403-414. doi: 10.1038/onc.2017.328. Epub 2017 Oct 2.
9
High density of CXCL12-positive immune cell infiltration predicts chemosensitivity and recurrence-free survival in ovarian carcinoma.CXCL12 阳性免疫细胞浸润密度预测卵巢癌的化疗敏感性和无复发生存。
J Cancer Res Clin Oncol. 2023 Dec;149(20):17943-17955. doi: 10.1007/s00432-023-05466-8. Epub 2023 Nov 15.
10
Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.基于免疫浸润的卵巢癌三种分子亚型的鉴定及其预后价值。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20201431.
引用本文的文献
1
Impact of sympathetic nervous system on immune evasion in high-grade serous ovarian cancer: a review.交感神经系统对高级别浆液性卵巢癌免疫逃逸的影响：综述
Front Oncol. 2025 Aug 8;15:1644895. doi: 10.3389/fonc.2025.1644895. eCollection 2025.
2
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.基于生物信息学和机器学习的子宫内膜异位症与复发性流产相关的潜在生物标志物及免疫浸润
Front Mol Biosci. 2025 Feb 3;12:1529507. doi: 10.3389/fmolb.2025.1529507. eCollection 2025.
本文引用的文献
1
Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma.标志性特征指导下的新型免疫相关特征的鉴定与表征，用于预测I-III期肺腺癌的复发情况。
Genes Dis. 2022 Aug 5;10(4):1657-1674. doi: 10.1016/j.gendis.2022.07.005. eCollection 2023 Jul.
2
Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.鉴定与肿瘤免疫表型相关的基因特征，用于预测肝细胞癌的预后、免疫治疗疗效和药物候选物。
Front Immunol. 2022 Apr 12;13:862527. doi: 10.3389/fimmu.2022.862527. eCollection 2022.
3
Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds.基于肿瘤免疫表型特征的高通量筛选以发现联合免疫治疗化合物。
Sci Adv. 2021 Jan 22;7(4). doi: 10.1126/sciadv.abd7851. Print 2021 Jan.
4
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.癌症微环境中的趋化因子及其在癌症免疫治疗中的相关性。
Nat Rev Immunol. 2017 Sep;17(9):559-572. doi: 10.1038/nri.2017.49. Epub 2017 May 30.
Zotero 插件